share_log

康辰药业监事会对《董事会关于2023年年报审计报告强调事项段涉及事项消除的专项说明》的意见

The board of supervisors of Beijing Konruns Pharmaceutical has opinions on the special statement concerning the elimination of matters related to the emphasis section of the audit report on the 2023 annual report by the board of directors.

SZSI ·  Jul 3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more